I was doing some DD on our CTGI instruments in Russian and saw a picture in which they had 19 tools including the generator
The development of the two present approved tools from he universal device to provide more flexibility to make the procedure automatic has been achieved more error free as compared to other systems.
As a result of the speed in which vessels can be sealed I think that this may also lead to less of a use for hemostats and clamps but I am not sure and other associated problems.
Wwhere is Joe Synder can he answer this?
I looked at some companies such as Starion that use low thermal energy and pressure to do their electo surgery but can't help to think about what can happen even using low thermal energy.
If body temeperature is brought do t down by anesthesia that there can still be burning or tissue damage or lack of sealing or sticking as a result of this.
My DD shows that radiopfrequency instruments have a 9% market share and that there is an 18% compounded annual growth rate for radioffrequency instruments
General and specialty procedures within conventional electrorsouurgery sector total about 17 Million procedures annually in e U.S. and expected to grow to 20 Million n by 2010
By 2010 ,Laparscopic and medical devices are expected to grow to $18.5Billion
The big majors dominates this space like Johnson and Johnson,Tyco Health care and Baxter otherwise they will acquire what they don't have
Gyrus acquired ACMI in 2005-Thermal therapy
Olympus acquired GYRUS in 2007- radiofrequency
In May 2008,OMrix got FDA approval for their Fibrin patch and got acquired by Johnson and Johnson for $483M in November
Since 2004 this industry has been consolidated by over 18 mergers and acquisitions since 2004
So if CTGI is eventually successful we may become takeover bait
I don't know why we are at $.30 with FDA and EU approval even though we have no revenues the financial environment doesn't help either
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.